Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)

SHE:002349 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	222.94	219.28	212.65	247.7	212.23	160.7
Depreciation & Amortization	80.42	80.42	76.5	85.34	109.93	102.5
Other Amortization	0.16	0.16	-	-	2.84	3.18
Loss (Gain) From Sale of Assets	0.01	0.01	0.2	0.09	0.06	0.58
Asset Writedown & Restructuring Costs	1.14	1.14	2.13	4.52	16.96	16.7
Loss (Gain) From Sale of Investments	-7.75	-7.75	-8.19	-7.07	-29.46	-31.44
Provision & Write-off of Bad Debts	0.46	0.46	3.37	2.72	4.26	14.59
Other Operating Activities	17.06	45.86	42.54	36.19	16.98	3.98
Change in Accounts Receivable	-13.2	-13.2	-11.17	-40.56	125.18	9.28
Change in Inventory	-17.73	-17.73	6.43	11.18	-27.82	-31.09
Change in Accounts Payable	13.19	13.19	-17.32	-46.61	-103.34	56.47
Change in Other Net Operating Assets	17.69	17.69	4.44	-5.05	29.53	-4.15
Operating Cash Flow	315.72	340.87	311.02	291.31	358.39	305.57
Operating Cash Flow Growth	-7.60%	9.60%	6.77%	-18.72%	17.29%	-6.90%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Capital Expenditures	-21.93	-20.32	-30.92	-28.38	-61.59	-80.55
Sale of Property, Plant & Equipment	0.02	0.05	0.12	0.26	0.09	2.61
Divestitures	-	-	-	-	71.41	0.41
Investment in Securities	-344.5	-465.75	-130.69	-191.24	91.1	4.32
Other Investing Activities	-56.09	16.44	11.69	6.99	7.58	4.23
Investing Cash Flow	-422.52	-469.59	-105.81	-212.37	108.59	-68.97

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Short-Term Debt Issued	-	-	10	20.9	85.52	70.07
Long-Term Debt Issued	-	-	-	-	3.3	-
Total Debt Issued	3	-	10	20.9	88.82	70.07
Short-Term Debt Repaid	-	-10	-20.9	-21	-163.9	-157.27
Long-Term Debt Repaid	-	-0.87	-1.34	-1.24	-29.7	-22.8
Total Debt Repaid	-11.07	-10.87	-22.24	-22.24	-193.6	-180.07
Net Debt Issued (Repaid)	-8.07	-10.87	-12.24	-1.34	-104.77	-110
Issuance of Common Stock	56.71	56.71	-	-	-	-
Common Dividends Paid	-65.2	-65.24	-75.55	-65.98	-54	-44.5
Other Financing Activities	-13.93	-14.31	-20.23	-26.84	-23.27	-21.71
Financing Cash Flow	-30.49	-33.71	-108.02	-94.16	-182.05	-176.21

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Foreign Exchange Rate Adjustments	-3.82	-2.27	2.13	2	4.1	-1.12
Net Cash Flow	-141.11	-164.71	99.32	-13.22	289.03	59.27

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	293.79	320.54	280.1	262.93	296.8	225.02
Free Cash Flow Growth	-8.06%	14.44%	6.53%	-11.41%	31.90%	7.28%
Free Cash Flow Margin	19.90%	21.96%	19.98%	17.39%	18.87%	16.57%
Free Cash Flow Per Share	0.36	0.39	0.34	0.32	0.36	0.28
Levered Free Cash Flow	245.63	293.18	186.18	132.98	198.73	69.94
Unlevered Free Cash Flow	245.92	293.54	187.01	134.59	202.98	78.03

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash Income Tax Paid	160.23	162.13	156.55	171.77	131.1	120.84
Change in Working Capital	1.28	1.28	-18.19	-78.17	24.6	34.78

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error